Apellis Pharmaceuticals buy RudolfL
Start price
03.04.22
/
50%
€52.04
Target price
03.04.23
€69.00
Performance (%)
31.30%
End price
24.08.22
€68.33
Summary
This prediction ended on 24.08.22 with a price of €68.33. With a performance of 31.30% the BUY prediction by RudolfL was a big success. RudolfL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Apellis Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
Comments by RudolfL for this prediction
In the thread Apellis Pharmaceuticals diskutieren
Kursziel geändert auf 69,0
In the thread Trading Apellis Pharmaceuticals
Stopped prediction by RudolfL for Apellis Pharmaceuticals
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€25.01
13.10.24
13.10.24
-
13.10.25
13.10.25
10.38%
10.01.25
10.01.25
